Published in Health and Medicine Week, January 19th, 2004
In September, Connetics announced positive results from its phase III clinical trial with Actiza versus Clindagel for the treatment of acne. Based on pre-NDA discussions, the FDA indicated that this 505(b)(2) application qualifies for exclusion from a user fee assessment.
According to the National Institute of Arthritis, Musculoskeletal, and Skin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week